A European Phase III, multicentre, double-blind, randomised, placebo-controlled monotherapy study of Milnacipran for the treatment of the Fibromyalgia Syndrome
A European Phase III, multicentre, double-blind, randomised, placebo-controlled monotherapy study of Milnacipran for the treatment of the Fibromyalgia Syndrome
A European Phase III, multicentre, double-blind, randomised, placebo-controlled monotherapy study of Milnacipran for the treatment of the Fibromyalgia Syndrome
Status
Status :
Completed
Type of study
Phase III
Min. Age
18
Years old
Max. Age
70
Years old
Gender
All
Therapeutic area :
Central Nervous System
Disease :
Fibromyalgia
Study medication :
Milnacipran
Phase :
Phase III
Start Date :
21 February 2006
End date :
04 September 2007
Study ID :
F02207 GE 302
EudraCT/CTIS number :
2005-003137-40
Send by email